GINA 2019: a fundamental change in asthma management

Helen K. Reddel; J. Mark FitzGerald; Eric D. Bateman; Leonard B. Bacharier; Allan Becker; Guy Brusselle; Roland Buhl; Alvaro A. Cruz; Louise Fleming; Hiromasa Inoue; Fanny Wai-san Ko; Jerry A. Krishnan; Mark L. Levy; Jiangtao Lin; Søren E. Pedersen; Aziz Sheikh; Arzu Yorgancioglu; Louis-Philippe Boulet

doi:10.1183/13993003.01046-2019

GINA 2019: a fundamental change in asthma management

Helen K. Reddel, J. Mark FitzGerald, Eric D. Bateman, Leonard B. Bacharier, Allan Becker, Guy Brusselle, Roland Buhl, Alvaro A. Cruz, Louise Fleming, Hiromasa Inoue, Fanny Wai-san Ko, Jerry A. Krishnan, Mark L. Levy, Jiangtao Lin, Søren E. Pedersen, Aziz Sheikh, Arzu Yorgancioglu, Louis-Philippe Boulet

Research output: Contribution to journal › Editorial › peer-review

357 Citations (Scopus)

Abstract

GINA no longer recommends treating adults/adolescents with asthma with short-acting bronchodilators alone. Instead, they should receive symptom-driven (in mild asthma) or a daily corticosteroid-containing inhaler, to reduce risk of severe exacerbations.

Original language	English
Article number	1901046
Pages (from-to)	1-7
Number of pages	7
Journal	European Respiratory Journal
Volume	53
Issue number	6
DOIs	https://doi.org/10.1183/13993003.01046-2019
Publication status	Published - Jun 2019
Externally published	Yes

Access to Document

10.1183/13993003.01046-2019

Cite this

Reddel, H. K., FitzGerald, J. M., Bateman, E. D., Bacharier, L. B., Becker, A., Brusselle, G., Buhl, R., Cruz, A. A., Fleming, L., Inoue, H., Ko, F. W., Krishnan, J. A., Levy, M. L., Lin, J., Pedersen, S. E., Sheikh, A., Yorgancioglu, A., & Boulet, L.-P. (2019). GINA 2019: a fundamental change in asthma management. European Respiratory Journal, 53(6), 1-7. Article 1901046. https://doi.org/10.1183/13993003.01046-2019

@article{0a8493b382b142ec839fe116748263ac,

title = "GINA 2019: a fundamental change in asthma management",

abstract = "GINA no longer recommends treating adults/adolescents with asthma with short-acting bronchodilators alone. Instead, they should receive symptom-driven (in mild asthma) or a daily corticosteroid-containing inhaler, to reduce risk of severe exacerbations.",

author = "Reddel, \{Helen K.\} and FitzGerald, \{J. Mark\} and Bateman, \{Eric D.\} and Bacharier, \{Leonard B.\} and Allan Becker and Guy Brusselle and Roland Buhl and Cruz, \{Alvaro A.\} and Louise Fleming and Hiromasa Inoue and Ko, \{Fanny Wai-san\} and Krishnan, \{Jerry A.\} and Levy, \{Mark L.\} and Jiangtao Lin and Pedersen, \{S{\o}ren E.\} and Aziz Sheikh and Arzu Yorgancioglu and Louis-Philippe Boulet",

year = "2019",

month = jun,

doi = "10.1183/13993003.01046-2019",

language = "English",

volume = "53",

pages = "1--7",

journal = "European Respiratory Journal",

issn = "0903-1936",

publisher = "European Respiratory Society",

number = "6",

}

Reddel, HK, FitzGerald, JM, Bateman, ED, Bacharier, LB, Becker, A, Brusselle, G, Buhl, R, Cruz, AA, Fleming, L, Inoue, H, Ko, FW, Krishnan, JA, Levy, ML, Lin, J, Pedersen, SE, Sheikh, A, Yorgancioglu, A & Boulet, L-P 2019, 'GINA 2019: a fundamental change in asthma management', European Respiratory Journal, vol. 53, no. 6, 1901046, pp. 1-7. https://doi.org/10.1183/13993003.01046-2019

TY - JOUR

T1 - GINA 2019

T2 - a fundamental change in asthma management

AU - Reddel, Helen K.

AU - FitzGerald, J. Mark

AU - Bateman, Eric D.

AU - Bacharier, Leonard B.

AU - Becker, Allan

AU - Brusselle, Guy

AU - Buhl, Roland

AU - Cruz, Alvaro A.

AU - Fleming, Louise

AU - Inoue, Hiromasa

AU - Ko, Fanny Wai-san

AU - Krishnan, Jerry A.

AU - Levy, Mark L.

AU - Lin, Jiangtao

AU - Pedersen, Søren E.

AU - Sheikh, Aziz

AU - Yorgancioglu, Arzu

AU - Boulet, Louis-Philippe

PY - 2019/6

Y1 - 2019/6

N2 - GINA no longer recommends treating adults/adolescents with asthma with short-acting bronchodilators alone. Instead, they should receive symptom-driven (in mild asthma) or a daily corticosteroid-containing inhaler, to reduce risk of severe exacerbations.

AB - GINA no longer recommends treating adults/adolescents with asthma with short-acting bronchodilators alone. Instead, they should receive symptom-driven (in mild asthma) or a daily corticosteroid-containing inhaler, to reduce risk of severe exacerbations.

UR - https://www.scopus.com/pages/publications/85068992340

U2 - 10.1183/13993003.01046-2019

DO - 10.1183/13993003.01046-2019

M3 - Editorial

C2 - 31249014

SN - 0903-1936

VL - 53

SP - 1

EP - 7

JO - European Respiratory Journal

JF - European Respiratory Journal

IS - 6

M1 - 1901046

ER -

GINA 2019: a fundamental change in asthma management

Abstract

Access to Document

Other files and links

Fingerprint

Cite this